Welcome to the Journal of Evidence Based Medicine, a premier platform dedicated to advancing the field of health policy and medicine through rigorous research and scholarship. Published by WILEY, this esteemed journal, with an ISSN of 1756-5383 and E-ISSN 1756-5391, is headquartered in the United Kingdom and serves as a pivotal resource for disseminating high-quality evidence-based research. Operating within the converged years from 2008 to 2024, the journal boasts a remarkable standing, achieving a Q1 category ranking in both Health Policy and Medicine (Miscellaneous) for 2023, and ranking #12 out of 310 in the Scopus Ranks for Medicine & Health Policy, placing it in the 96th percentile. This commitment to excellence makes the journal a significant conduit for professionals, researchers, and students who seek to inform their practices with the latest evidence and foster advancements in health policy and medical practice. While currently not open access, the journal maintains a rigorous selection process to ensure the highest standards of publication, appealing to anyone intent on exploring groundbreaking studies that shape the health landscape globally.

Reviews on Recent Clinical Trials, published by Bentham Science Publishers Ltd, is a distinguished journal in the medical and pharmacological fields, assessing the latest advancements in clinical research since its inception in 2006. With a focus on integrating multidisciplinary approaches to evaluating clinical trial methodologies, the journal caters to a diverse audience of researchers, professionals, and students keen on enhancing their knowledge and understanding of innovative therapeutic strategies and drug developments. Notably positioned in the Q3 quartile as ranked by Scopus for both 'Medicine (miscellaneous)' and 'Pharmacology', the journal illustrates a growing academic influence, evidenced by its Scopus rankings—holding a commendable 72nd percentile in general medicine and a 33rd percentile in pharmacology. While the journal is not open access, it remains committed to disseminating high-quality, peer-reviewed content that drives forward the conversation in clinical research. For those interested in staying abreast of novel findings and comprehensive reviews within the clinical trial landscape, Reviews on Recent Clinical Trials stands out as an essential resource.

Biological Research for Nursing, published by SAGE Publications Inc, stands at the forefront of scholarly innovation in the field of nursing, focusing particularly on integrating biological research into nursing practice and research methodologies. With an ISSN of 1099-8004 and an E-ISSN of 1552-4175, this esteemed journal has established itself as a vital resource for nursing professionals, researchers, and students, achieving a remarkable Q1 ranking in the Research and Theory category as well as being ranked #2 out of 18 in Nursing Research and Theory with a 91st percentile. Bridging the gap between biological sciences and nursing, this journal aims to publish high-quality research that explores the biological underpinnings of nursing practices, advancing theory and evidence-based practice since its inception in 1999. As we approach the year 2024, readers can expect cutting-edge research, theoretical advancements, and comprehensive reviews that empower the nursing community to enhance patient care through a deeper understanding of biological influences. While not an open access journal, it remains widely accessible through institutional subscriptions, ensuring that scholars from diverse backgrounds can engage with its rich content.

The Journal of Vascular Nursing is a premier publication dedicated to advancing the field of vascular nursing, addressing critical issues related to the management and treatment of vascular conditions. Published by Elsevier Science Inc, this esteemed journal boasts an ISSN of 1062-0303 and an E-ISSN of 1532-6578. With a notable impact factor and ranked in the top 39% of journals within the Medical and Surgical Nursing category (Q1), it provides a vital platform for the dissemination of innovative research, clinical practice updates, and evidence-based approaches. Since its inception in 1990, the journal has continued to evolve, offering its readership insights that bridge theory and practice, which are crucial for and beneficial to both seasoned professionals and those entering the field. The Journal of Vascular Nursing is invaluable for anyone invested in enhancing patient outcomes and nursing practices within the realm of vascular health.

ANNALS OF INTERNAL MEDICINE, published by the American College of Physicians, stands as one of the leading journals in the field of internal medicine, with an impressive impact factor that underscores its significance in academic discourse. Since its inception in 1945, this esteemed journal has maintained a steadfast commitment to publishing high-quality research that spans a broad spectrum of internal medicine, making substantial contributions to clinical practice and health policy. With a current ranking of #5 out of 167 in the field of Internal Medicine and a remarkable 97th percentile ranking in literature, the ANNALS OF INTERNAL MEDICINE is recognized as a vital resource for researchers, healthcare professionals, and students alike. Although it operates under a traditional subscription model, the journal continually emphasizes the importance of disseminating robust clinical trials, systematic reviews, and expert commentaries that advance medical knowledge and practice. Its quartile rankings in Q1 for both Internal Medicine and Miscellaneous Medicine highlight its role in shaping the future of healthcare through rigorous and impactful scientific inquiry.

Journal of Yeungnam Medical Science, published by Yeungnam University College of Medicine and the Yeungnam University Institute of Medical Science, is an innovative open-access journal dedicated to advancing knowledge in the medical sciences. Launched in 2018, this journal encourages the dissemination of high-quality research across a broad range of medical disciplines, reinforcing its commitment to enhancing the global health community. With an E-ISSN of 2799-8010, the journal is centrally located in Daegu, South Korea, and aims to bridge the gap between research and practical application, offering a platform for researchers, professionals, and students. Although the journal is still garnering recognition, as reflected in its overall ranking within the Scopus Multidisciplinary category, it promises to play a vital role in fostering scientific exchange and collaboration. The focus on open access further ensures that groundbreaking research is readily available to a wider audience, aligning with contemporary scholarly communication trends.

JBI Evidence Synthesis is a premier peer-reviewed journal published by Lippincott Williams & Wilkins, dedicated to advancing the field of evidence-based practice in nursing. With an impressive Q1 ranking in the 2023 category of Nursing (Miscellaneous) and holding the rank of #25 out of 139 in General Nursing according to Scopus, this journal serves as a key resource for researchers, practitioners, and students alike. Its focus on synthesizing high-quality research evidence allows for the integration of best practices into clinical settings, thereby enhancing patient care and health outcomes. Since its inception, JBI Evidence Synthesis has been committed to promoting rigorous methodologies and innovative approaches in evidence synthesis, making it an essential publication for anyone seeking to contribute to the advancement of nursing and healthcare. The journal is available in both print and online formats, ensuring wide accessibility to critical knowledge in the field.

Welcome to the Journal of Patient-Reported Outcomes, a premier platform dedicated to advancing the field of health informatics and health information management. Published by SPRINGERNATURE since 2017, this Open Access journal allows researchers and practitioners globally to disseminate vital research findings, ensuring that insights into patient-reported outcomes reach a wider audience without barriers. With its current standing in the Q2 quartile for both Health Informatics and Health Information Management in 2023, it is positioned as a significant contributor to the healthcare research community, ranking 76th out of 138 in Medicine and 34th out of 59 in Health Professions. The journal aims to publish high-quality, peer-reviewed articles that explore innovative methodologies, enhance clinical decision-making, and ultimately improve patient care outcomes. By offering a platform for interdisciplinary collaboration, the Journal of Patient-Reported Outcomes fosters a deeper understanding of patients' perspectives in healthcare, making it an essential resource for researchers, professionals, and students alike.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, published by SAGE Publications Ltd, serves as a vital platform in the fields of biochemistry and medicine, showcasing significant research contributions since its inception in 1972. With an Open Access policy implemented in 2012, this journal promotes unrestricted dissemination of knowledge, catering to a global audience and ensuring that critical findings are accessible to researchers, healthcare professionals, and students alike. With an impressive scope spanning diverse biomedical disciplines, the journal ranks in the Q3 quartile for both biochemistry and medicine, affirming its relevance and impact within these evolving fields. Hailing from the United Kingdom, the journal is dedicated to fostering a rich academic dialogue that bridges laboratory discoveries and clinical applications, making it an essential resource for those engaged in international medical research. Its ongoing commitment to excellence is reflected in its convergence until 2024, inviting high-quality submissions that contribute to advancements in medical science.

HEALTH TECHNOLOGY ASSESSMENT is a prestigious open-access journal published by the NIHR Journals Library, focusing on advancing the science of health technology assessment through robust research and critical analysis in the fields of Health Policy and Medicine. Since its inception in 2001, this journal has fostered a multidisciplinary approach to evaluating health technologies, offering invaluable insights to researchers, healthcare professionals, and policymakers. With an impressive Q1 ranking in both Health Policy and Medicine (miscellaneous) for 2023, it stands at the forefront of academic discourse, reflecting a high-impact factor and an esteemed reputation within its respective categories. The journal not only publishes original research articles, but also reviews and case studies that illuminate the complexities of health technology in real-world applications. Established and based in the United Kingdom, HEALTH TECHNOLOGY ASSESSMENT strives to encourage evidence-based decision-making, making it an essential resource for anyone committed to enhancing healthcare outcomes through innovative technology assessments.